戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 s using a primer-template complex containing 2-aminopurine.
2  hitherto undetected physicochemical form of 2-aminopurine.
3 lated by PKR, and this could be inhibited by 2-aminopurine.
4 the fluorescent adenosine analogue 2'-deoxy, 2-aminopurine.
5 l with an emission maximum characteristic of 2-aminopurine.
6 Y mutator background or after treatment with 2-aminopurine.
7 stigated using the fluorescent purine analog 2-aminopurine.
8 lectively incorporated the fluorescent probe 2-aminopurine 2'-O-methylriboside (2-AP) into the RRE se
9 oter of Escherichia coli was investigated by 2-aminopurine (2,AP) fluorescence.
10                          Although the use of 2-aminopurine (2-AP) as a probe in stopped-flow analyses
11 le substitutions of the fluorescent A-analog 2-aminopurine (2-AP) at -11 and two other positions in p
12                 By inserting the base analog 2-aminopurine (2-AP) at designated positions in 89 bp an
13 g a synthetic DNA primer/template containing 2-aminopurine (2-AP) at the template position opposite t
14 aperone activity in the DIS conversion using 2-aminopurine (2-AP) fluorescence and nuclear magnetic r
15 ryptophan fluorescence in the polymerase and 2-aminopurine (2-AP) fluorescence in the promoter DNA up
16                            The PKR inhibitor 2-aminopurine (2-AP) inhibited TNF-alpha/IFN-gamma-induc
17 ctive incorporation of the fluorescent probe 2-aminopurine (2-AP) into a truncated form of the RRE se
18                The fluorescent base analogue 2-aminopurine (2-AP) is commonly used to study specific
19                                        Using 2-aminopurine (2-AP) labeled sequences derived from the
20 age T7 RNA polymerase was investigated using 2-aminopurine (2-AP) modified promoters.
21 template DNA constructs with 1 or 2 adjacent 2-aminopurine (2-AP) nucleotide residues (adenine analog
22 bstrates containing the fluorescent reporter 2-aminopurine (2-AP) on the template strand, either at t
23 se protein kinase pathway by the addition of 2-aminopurine (2-AP) prior to the ODP arrests CHO cells
24 n-specifically labeled with monomer or dimer 2-aminopurine (2-AP) probes to map the local interaction
25 mploy short (86 bp) synthetic promoters with 2-aminopurine (2-AP) substitutions in the region that be
26 used DNA containing the fluorescent reporter 2-aminopurine (2-AP) to study the reaction pathway of th
27 anscription is activated in AMphi and PMphi, 2-aminopurine (2-AP) was used to block dsRNA-mediated ac
28  analogs [inosine (I), purine riboside (PR), 2-aminopurine (2-AP), 2,6-diaminopurine (2,6-DAP), isogu
29                                              2-Aminopurine (2-AP), a fluorescent analog of adenine, h
30 ution of A in the standing start position by 2-aminopurine (2-AP), a fluorescent base analogue.
31                               Treatment with 2-aminopurine (2-AP), a serine/threonine kinase inhibito
32 4(2-AP)T5), containing the fluorescent base, 2-aminopurine (2-AP), and dT(pT)15 labeled at its 3'-end
33   We have used a fluorescent adenine analog, 2-aminopurine (2-Ap), as a probe of local double helical
34 corporating the fluorescent nucleotide probe 2-aminopurine (2-AP), opposite to the site (AB-APopp) or
35       The fluorescent adenine base analogue, 2-aminopurine (2-AP), placed opposite an abasic site ana
36 strains are sensitive to the DNA base analog 2-aminopurine (2-AP), we screened for 2-AP-resistant (2-
37                     Interaction of VP55 with 2-aminopurine (2-AP)-containing primers was associated w
38  quartz substrate from the DNA base analogue 2-aminopurine (2-AP).
39 t to a fluorescent nucleotide reporter group 2-aminopurine (2-AP).
40 hase cells with the protein kinase inhibitor 2-aminopurine (2-AP).
41 stituted with the fluorescent reporter base, 2-aminopurine (2-AP).
42 tures using the fluorescent adenine analogue 2-aminopurine (2-AP).
43 TG) in DNA can be converted to S6-methylthio-2-aminopurine (2-AP-6-SCH3) and 2-aminopurine-6-sulfonic
44                       The fluorescent probe, 2-aminopurine-2'-O-methyl riboside (2-AP) has been selec
45                 The base pair formed between 2-aminopurine (2AP) and cytosine (C) is an intermediate
46 e determined using RNA hairpins labeled with 2-aminopurine (2AP) and monitoring the fluorescence chan
47 he nucleodyes make good FRET pairs with both 2-aminopurine (2AP) and pyrrolocytosine (PyC).
48                                 We have used 2-aminopurine (2AP) as a fluorescent probe in the templa
49                                              2-Aminopurine (2AP) fluorescence intensity and decay lif
50          Circular dichroism spectroscopy and 2-aminopurine (2AP) fluorescence studies show no evidenc
51 ucleotide that is melted by the mtRNAP using 2-aminopurine (2AP) fluorescence that is sensitive to ch
52 e been examined using time-resolved FRET and 2-aminopurine (2AP) fluorescence.
53  (CAG)n repeat, we have substituted a single 2-aminopurine (2AP) fluorescent base for adenine at sele
54               The fluorescent adenine analog 2-aminopurine (2AP) has been used extensively to monitor
55                                              2-Aminopurine (2AP) is a fluorescent analog of guanosine
56                                              2-Aminopurine (2AP) is an analogue of adenine that has b
57 ymerase (T4 pol) to primer-template DNA with 2-aminopurine (2AP) located at the primer terminus resul
58 y-state fluorescence of the adenine analogue 2-aminopurine (2AP) opposite an abasic site demonstrated
59             In both cases, the base analogue 2-aminopurine (2AP) proved tremendously useful-first as
60 ocesses were triggered by photoexcitation of 2-aminopurine (2AP) residues site-specifically positione
61 e have used the fluorescent adenine analogue 2-aminopurine (2Ap) to probe the local double-helical st
62          Here we describe the application of 2-aminopurine (2AP), a fluorescent isomer of adenine, to
63  of this riboswitch and the ligands adenine, 2-aminopurine (2AP), and 2,6-diaminopurine (DAP).
64  archetypical fluorescent nucleoside analog, 2-aminopurine (2Ap), has been used in countless assays,
65 sessed using the fluorescent purine analogue 2-aminopurine (2AP), incorporating 2AP between purine an
66 uorescence lifetimes of the adenine analogue 2-aminopurine (2AP), replacing adenine opposite the urac
67 e employed, containing the fluorescent base, 2-aminopurine (2AP), substituted at the -11 position in
68          In many of these analogues, such as 2-aminopurine (2AP), the fluorescence is quenched when i
69 base-modified nucleotides 2,6-diaminopurine, 2-aminopurine, 6-chloropurine, and inosine which would m
70 6-methylthio-2-aminopurine (2-AP-6-SCH3) and 2-aminopurine-6-sulfonic acid (2-AP-6-SO3H) upon reactio
71                   The fluorescent nucleotide 2-aminopurine (a*) reports mainly on base stacking.
72  commonly used fluorescent ribonucleoside is 2-aminopurine, a highly responsive purine analogue.
73                                        Since 2-aminopurine, a serine/threonine kinase inhibitor that
74                              Substitution of 2-aminopurine adjacent to the target base also results i
75           Finally, replacement of adenine by 2-aminopurine (AG --> 2-APG) had no effect on the second
76  fluorescence measurements of DNA containing 2-aminopurine allowed presteady-state real time observat
77 d thymine is just the first excited state of 2-aminopurine alone.
78 , treatment of porcine and bovine cells with 2-aminopurine, an inhibitor of PKR, increased the yield
79 oring the population of an initially excited 2-aminopurine, an isomer of adenine, we can follow the c
80      It relies on strategic incorporation of 2-aminopurine, an isosteric fluorescent adenosine analog
81 ding model with two intermediates, while the 2-aminopurine analogs required one intermediate.
82  dichroism (CD), fluorescence of adenine --> 2-aminopurine analogs, and fluorescence resonance energy
83                                      Various 2-aminopurine analogues of AdA were synthesized, all of
84 uplexes carried fluorescent DNA base analogs 2-aminopurine and 1,3-diaza-2-oxophenoxazine as environm
85        Studies with the nucleotide analogues 2-aminopurine and 2,6-diaminopurine indicated that this
86                             Prior studies of 2-aminopurine and 7-deazaguanine effects had shown that
87 ase in photostability of a DNA base analogue 2-aminopurine and a coumarin derivative (7-HC) in 10-nm
88 hosphorylation of PKR and inhibitors of PKR, 2-aminopurine and adenine, ablated poly(I:C)-induced gen
89     The fluorescence emission spectra of the 2-aminopurine and FRET derivatives suggest greater solve
90 otein kinase R (PKR) dependent (abrogated by 2-aminopurine and greatly reduced in PKR-/- cells).
91 loped a rapid fluorescence-based assay using 2-aminopurine and measured the steady-state rate constan
92                                     By using 2-aminopurine and purine as the templating residues, whi
93     The fluorescence of the adenine analogue 2-aminopurine and the cytosine analogue pyrrolocytosine
94 ate) of a hydrogen-bonded complex containing 2-aminopurine and thymine is just the first excited stat
95 species is not a covalently modified form of 2-aminopurine and we suggest that it represents a hither
96  poorly in the presence of the base analogue 2-aminopurine, and exposure to the base analogue results
97 urements with site-specifically incorporated 2-aminopurine, and functional assays indicate that the n
98 ence of the yield of CT between photoexcited 2-aminopurine (Ap) and G through DNA bridges of varied l
99 MB-FB) which uses the fluorescent bases (FB) 2-aminopurine (AP) and pyrrolo-dC (P-dC) as fluorophores
100 uplex by examining photoinduced quenching of 2-aminopurine (Ap) as a result of hole transfer (HT) to
101  sequence-specific hydration dynamics, using 2-aminopurine (Ap) as the intrinsic fluorescence probe a
102 nts of analogous primer-templates containing 2-aminopurine (AP) at the primer 3' terminus indicate th
103 conformational changes upon catalysis, while 2-aminopurine (AP) fluorescence assays have detected con
104 ere, we use the fluorescent guanine analogue 2-aminopurine (AP) in nucleotide position 76, immediatel
105                                              2-Aminopurine (AP) is a highly mutagenic base analog.
106 or RNA that is based on the use of the CD of 2-aminopurine (AP) residues as a probe.
107                              The base analog 2-aminopurine (AP) strongly promotes A.T to G.C and G.C
108  in which a fluorescent nucleobase analogue, 2-aminopurine (AP), occupies defined positions with resp
109 ans-cleaving HDV ribozyme to the fluorescent 2-aminopurine (AP), we can directly monitor local confor
110  and DNA:RNA hybrids containing photoexcited 2-aminopurine (Ap).
111                                        Using 2-aminopurine as a dangling end purine base, we have emp
112                                         With 2-aminopurine as a fluorescent reporter in the DNA subst
113                                        Using 2-aminopurine as a site-specific fluorescent probe in pl
114  is the recognition of 2,6-diaminopurine and 2-aminopurine, as confirmed in crystal structures of res
115                                              2-Aminopurine at positions +3, +4, or +5 in the nonsciss
116 olymerase binding to promoters incorporating 2-aminopurine at positions -4 through -1 support a model
117 d to synthetic tRNA(1)(Leu) substituted with 2-aminopurine at positions 36 and 37, fluorescence energ
118  capture the ultrafast decay dynamics of the 2-aminopurine base as the ligand, we have detected the p
119 energy transfer from normal DNA bases to the 2-aminopurine base in synthesized DNA oligomers were inv
120 ribonucleotide substrate containing a uracil:2-aminopurine base pair.
121                                       Single 2-aminopurine bases are introduced into otherwise standa
122                             On binding CCE1, 2-aminopurine bases located at the point of strand excha
123 or conformational probes comprising pairs of 2-aminopurine bases site-specifically replacing adenine
124                                     Stacking 2-aminopurine between two guanine moieties is shown to s
125 (5)M(-1)s(-1) and 2.1 x 10(5)mM(-1)s(-1) for 2-aminopurine binding the adenine-responsive mutant ribo
126  reduced markedly by treatment of cells with 2-aminopurine but not by genistein.
127 lycosylase activity on 2-aminopurine/G and A/2-aminopurine but weaker activity on A/C than E. coli Mu
128      Stopped-flow fluorescence studies using 2-aminopurine-containing oligodeoxyribonucleotides furth
129 om GTP binding to polymerase and fluorescent 2-aminopurine-containing promoter DNA complex.
130   The ability of protein-Ca(2+) to rearrange 2-aminopurine-containing substrates was monitored by low
131 via a disulfide bond, 2'-deoxy-6-(cystamine)-2-aminopurine (d6Cys2AP) was synthesized and incorporate
132 ol)-primer-template (P/T) complex containing 2-aminopurine (dAP) and a metal exchange-inert Rh(III) d
133      Equilibrium binding studies utilizing a 2-aminopurine deoxypseudouridine DNA substrate showed th
134            At neutral pH, RNAs with adenine, 2-aminopurine, dimethyladenine or purine substitutions a
135  revealed upon GTP binding to the polymerase.2-aminopurine DNA complex.
136  DNA bending by FRET and DNA unpairing using 2-aminopurine exciton pair CD to determine the DNA and p
137 and filamentation phenotypes associated with 2-aminopurine exposure are effectively suppressed by nul
138 o the IRE-RNA, altering its conformation (by 2-aminopurine fluorescence and ethidium bromide displace
139                                     By using 2-aminopurine fluorescence as the base flipping probe we
140 atomic force microscopy (AFM) supported by a 2-aminopurine fluorescence base flipping assay to study
141 uishable observed rate constants of FRET and 2-aminopurine fluorescence changes indicate that DNA ben
142                      Similarly, stopped-flow 2-aminopurine fluorescence changes showed that promoter
143 l-methionine to the M.EcoKI:DNA complex, the 2-aminopurine fluorescence changes to that of a new spec
144      Stopped-flow fluorometry monitoring the 2-aminopurine fluorescence defined the kinetics of uraci
145                                              2-Aminopurine fluorescence experiments indicate that thi
146                 The slowest step detected by 2-aminopurine fluorescence increase is assigned to the f
147 ition of the correct NTP to the T7 RNAP-DNA, 2-aminopurine fluorescence increased rapidly and exponen
148                         Thus it appears that 2-aminopurine fluorescence intensity is not a clear indi
149      Base-flipping kinetics (monitored using 2-aminopurine fluorescence intensity) were essentially s
150                              The increase in 2-aminopurine fluorescence is specific to the editing si
151          M247 appears to be unimportant, but 2-aminopurine fluorescence measurements show that Y261 p
152 eous DNA duplexes that is based on combining 2-aminopurine fluorescence measurements with a new quant
153  transfer analysis showed that a decrease in 2-aminopurine fluorescence occurs only when AdoMet is pr
154 ously reported that ADAR2 induced changes in 2-aminopurine fluorescence of a modified substrate, cons
155 re similar, and both NC and Gag affected the 2-aminopurine fluorescence of bases close to the loop bi
156                         Here, we use NMR and 2-aminopurine fluorescence spectroscopy to examine how D
157 ional dynamics, as detected by time-resolved 2-aminopurine fluorescence spectroscopy.
158 g fluorescence resonance energy transfer and 2-aminopurine fluorescence studies reveals that DNA bend
159                                      We used 2-aminopurine fluorescence to monitor promoter melting a
160 ion uses both steady-state and time-resolved 2-aminopurine fluorescence to show pronounced unwinding
161  Tel22 by circular dichroism (CD), intrinsic 2-aminopurine fluorescence, and fluorescence resonance e
162                                        Using 2-aminopurine fluorescence-based equilibrium and kinetic
163 scence resonance energy transfer (FRET), and 2-aminopurine fluorescence.
164 mplex formation leads to a rapid increase of 2-aminopurine fluorescence.
165 myces cerevisiae has been investigated using 2-aminopurine fluorescence.
166 nter of the DNA junction that is observed by 2-aminopurine fluorescence.
167 diated CT across adenine tracts monitored by 2-aminopurine fluorescence.
168  reported directly from the mismatch site by 2-aminopurine fluorescence.
169 tegic and systematic single-substitutions of 2-aminopurine for adenine bases.
170                          The substitution of 2-aminopurine for adenine on the probe DNA sequence enab
171    SpMYH has greater glycosylase activity on 2-aminopurine/G and A/2-aminopurine but weaker activity
172 y was completely inhibited by chelerythrine, 2-aminopurine, genistein, and W-7 and only partially or
173                                 We find that 2-aminopurine gives enhanced fluorescence emission not o
174                          The fluorescence of 2-aminopurine has been previously shown to depend on the
175         Use of the fluorescent base analogue 2-aminopurine has provided a direct demonstration of the
176 rs of magnitude (from 5.9 nM to 0.59 mM) for 2-aminopurine in a 1 cm x 0.17 cm fluorescence cuvette.
177             M.PspGI enhances fluorescence of 2-aminopurine in DNA if it replaces the second C in the
178 y monitoring the increase in fluorescence of 2-aminopurine in DNA-T7 RNA polymerase complexes, we obt
179 ach, we insert the fluorescent base analogue 2-aminopurine in place of A1492 in an E. coli 16S rRNA A
180 lates containing the fluorescent base analog 2-aminopurine in place of adenine at specific positions
181  DNA internally labeled with the base analog 2-aminopurine in place of adenine to monitor transcripti
182 ylated DNA containing the fluorescent analog 2-aminopurine in place of the target adenine.
183 rgy CD spectra and fluorescence lifetimes of 2-aminopurine in substrates and products that were indic
184 al folding kinetics of a ribozyme containing 2-aminopurine in the loop of P9.
185 g FRET between end labels or fluorescence of 2-aminopurine in the stem as conformational probes, yiel
186                Specific inhibition of PKR by 2-aminopurine in these FA BM cells attenuates PKR activa
187                          The fluorescence of 2-aminopurine increases when the DNA goes from a double-
188  same cannot be said for structures in which 2-aminopurine is base stacked with other nucleobases.
189 ne dimer, and no changes are detected if the 2-aminopurine is moved opposite the 3'-thymine of the py
190  structure is available, the fluorescence of 2-aminopurine is often used as a signal for base flippin
191 th the identity of the nucleobase with which 2-aminopurine is stacked.
192 des on the femtosecond dynamics of boxB RNA (2-aminopurine labeled in different positions), through m
193 tigate the nature of PAP domain flexibility, 2-aminopurine labeled molecular probes were employed in
194 5 peptides using fluorescent titrations with 2-aminopurine labeled versions of the three GNRA-folded
195 studies presented include the utilization of 2-aminopurine-labeled DNA substrates, 2-aminopurine nucl
196  emission maximum of a duplex substrate with 2-aminopurine located at the editing site, consistent wi
197  active enzyme, the correct cofactor and the 2-aminopurine located at the methylation site.
198 surements of a fluorescent adenine analogue (2-aminopurine) located at the 3'-primer terminus.
199                                          Our 2-aminopurine mapping studies show that the LSP (Light S
200                     A series of 13 new (S,Z)-2-aminopurine methylenecyclopropane analogues was synthe
201 es showed that HX RNA carrying a fluorescent 2-aminopurine modification provides a model system that
202 , and abasic modifications and G378/379 with 2-aminopurine, N7-deazaguanosine, and 6-thioguanosine.
203 each with a single, strategically positioned 2-aminopurine nucleobase substitution.
204 ups not only from N(6)-substituted purine or 2-aminopurine nucleoside monophosphates but also from O(
205 fically acts at the 6-position of purine and 2-aminopurine nucleoside monophosphates.
206 e with a quantum yield comparable to that of 2-aminopurine nucleoside.
207 ion of 2-aminopurine-labeled DNA substrates, 2-aminopurine nucleotide triphosphate, a nonhydrolyzable
208 using site-specific substitution of 2'-deoxy-2-aminopurine nucleotides at key adenosine positions.
209  influence of Gag on the fluorescence of the 2-aminopurine nucleotides at the base of the helix impli
210 ed the fluorescence intensity of one or more 2-aminopurine or 6-methylisoxanthopterin base analogs in
211    In cells pre-exposed to the PKR inhibitor 2-aminopurine or in PKR-null cells, the activation of p3
212 complexes, alteration of a guanine to either 2-aminopurine or nebularine resulted in an increase in K
213 changes were observed with G:pyrrolo dC or T:2-aminopurine pairs.
214                                          The 2-aminopurine phosphoramidite prepared by this method co
215 I was not affected by inhibition of PKR with 2-aminopurine, phosphorylation of MKK3/6 and p38 as well
216                           Substitutions with 2-aminopurine probe base exposure throughout this struct
217 rly conformational transition, reported by a 2-aminopurine probe, that takes place in the open ternar
218                                              2-Aminopurine probes at the upstream ends of the hairpin
219 ight bases upstream of the pause site, while 2-aminopurine probes show that the elongation bubble ext
220 on coupling in the CD spectra of dimer 2-AP (2-aminopurine) probes at various positions in the ssDNA
221 to be readily hydrogenated to give purine or 2-aminopurine products in good yield.
222 ced by one-electron oxidation of 8-oxoGua by 2-aminopurine radicals generated by the two-photon ioniz
223                   The fluorescent nucleobase 2-aminopurine replaced three individual adenines, two of
224 he mechanism for selective hydrolysis of the 2-aminopurine residue in alkaline solution is predominan
225             The presence and location of the 2-aminopurine residue is easily verified by treatment of
226 esis of oligodeoxyribonucleotides containing 2-aminopurine residues at selected sites.
227 spectra of site-specifically placed pairs of 2-aminopurine residues have been used to probe the roles
228                               We located the 2-aminopurine residues in the presumed melting domain of
229 by observing the increase in fluorescence of 2-aminopurine residues incorporated in the oligos.
230 ls generated by the two-photon ionization of 2-aminopurine residues site specifically positioned in 5
231 ergy CD and fluorescence spectra of pairs of 2-aminopurine residues that have been inserted at define
232              The advantage of using pairs of 2-aminopurine residues, inserted at defined nucleic acid
233                           Pyrrolocytosine or 2-aminopurine residues, site-specifically substituted fo
234       This method involves protection of the 2-aminopurine ribonucleoside, reduction to the deoxyribo
235 uantum yield of nucleotide analogues such as 2-aminopurine strongly depends on base stacking interact
236                                          Our 2-aminopurine studies show that helicase and polymerase
237 nce of RNA polymerase and DNA fragments with 2-aminopurine substituted at specific positions.
238 phasor diagrams is demonstrated here using a 2-aminopurine substituted telomeric G-quadruplex sequenc
239 ensemble, and fluorescence measurements with 2-aminopurine-substituted 3A-DNA provided initial tests
240                               The effects of 2-aminopurine substitution on the physical and structura
241 e of the HIV-1 packaging signal (Psi), using 2-aminopurine substitution to create a series of modifie
242 roperties of this hairpin are assessed using 2-aminopurine substitutions for adenine at six positions
243 base stacking on fluorescence quantum yield, 2-aminopurine substitutions for adenine previously demon
244           The fluorescence properties of the 2-aminopurine substitutions showed features consistent w
245               Fluorescence experiments using 2-aminopurine suggest that LNA modifications enhance bas
246 ed mutation frequency, the dam mutants had a 2-aminopurine-susceptible phenotype that could be suppre
247 ociation rates; e.g., the protein releases a 2-Aminopurine:T base pair approximately 90-fold faster t
248 dues site specifically positioned in 5'-d(CC[2-aminopurine]TC[8-oxoGua]CTACC).
249    By analyzing changes in fluorescence of a 2-aminopurine template base undergoing replication in re
250    This probe is up to 50-fold brighter than 2-aminopurine, the fluorescent nucleoside standard.
251 itored using the fluorescence intensities of 2-aminopurines, the changes in the intensity relative to
252 an experiment showing that installation of a 2-aminopurine-thymine base pair at the cross-linking sit
253             The fluorescent adenine analogue 2-aminopurine was incorporated at various single positio
254                   The fluorescent nucleotide 2-aminopurine was substituted at selected sites within t
255                  Using the fluorescent probe 2-aminopurine, we show that inhibitors interact with hig
256   Using single substitutions of adenine with 2-aminopurine, we show that intrastrand folding in repea
257 methyltransferase (GAATTC) was replaced with 2-aminopurine, which fluoresces upon excitation at 310 n
258                                         Like 2-aminopurine, which substitutes for adenine bases, the

 
Page Top